A mixed message for cystic fibrosis gene therapy
- 1 September 1994
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 8 (1) , 8-9
- https://doi.org/10.1038/ng0994-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisNature Genetics, 1994
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growthEuropean Respiratory Journal, 1994
- Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosisPublished by Elsevier ,1993
- Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant miceNature Genetics, 1993
- Mutations in CFTR associated with mild-disease-form CI- channels with altered pore propertiesNature, 1993
- Gene Transfer to Respiratory Epithelial Cells via the Receptor-mediated Endocytosis PathwayAmerican Journal of Respiratory Cell and Molecular Biology, 1992
- Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosisCell, 1990
- Relative ion permeability of normal and cystic fibrosis nasal epithelium.Journal of Clinical Investigation, 1983
- Increased Bioelectric Potential Difference across Respiratory Epithelia in Cystic FibrosisNew England Journal of Medicine, 1981